COLLEGIUM PHARMACEUTICAL, INC (COLL) Interest Expense USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Collegium Pharmaceutical, Inc quarterly/annual Interest Expense history and growth rate from 2015 to 2024.
  • Collegium Pharmaceutical, Inc Interest Expense for the quarter ending March 31, 2024 was $17.3 M, a 19.1% decline year-over-year.
  • Collegium Pharmaceutical, Inc Interest Expense for the twelve months ending March 31, 2024 was $79.3 M, a 0.56% increase year-over-year.
  • Collegium Pharmaceutical, Inc annual Interest Expense for 2023 was $83.3 M, a 31.8% increase from 2022.
  • Collegium Pharmaceutical, Inc annual Interest Expense for 2022 was $63.2 M, a 201% increase from 2021.
  • Collegium Pharmaceutical, Inc annual Interest Expense for 2021 was $21 M, a 27.2% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $79.3 M $17.3 M -$4.09 M -19.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $83.3 M $19.3 M -$1.29 M -6.29% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $84.6 M $20.8 M +$1.72 M +9.04% Jul 1, 2023 Sep 30, 2023 10-K 2024-02-22
Q2 2023 $82.9 M $21.9 M +$4.1 M +23.1% Apr 1, 2023 Jun 30, 2023 10-K 2024-02-22
Q1 2023 $78.8 M $21.4 M +$15.6 M +267% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $63.2 M $20.6 M +$15.8 M +333% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $47.4 M $19 M +$13.9 M +272% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-22
Q2 2022 $33.5 M $17.8 M +$12.3 M +228% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-22
Q1 2022 $21.1 M $5.83 M +$110 K +1.92% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-22
Q4 2021 $21 M $4.76 M -$2.98 M -38.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 $24 M $5.12 M -$2.95 M -36.6% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-23
Q2 2021 $26.9 M $5.42 M -$2.84 M -34.4% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-23
Q1 2021 $29.8 M $5.72 M +$898 K +18.6% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-23
Q4 2020 $28.9 M $7.74 M +$7.53 M +3567% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $21.4 M $8.06 M +$7.84 M +3436% Jul 1, 2020 Sep 30, 2020 10-K 2022-02-24
Q2 2020 $13.5 M $8.26 M +$8.02 M +3400% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-24
Q1 2020 $5.5 M $4.82 M +$4.59 M +1961% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-24
Q4 2019 $909 K $211 K -$2.19 M -91.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $3.1 M $228 K -$5.64 M -96.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 $8.74 M $236 K -$5.92 M -96.2% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 $14.7 M $234 K -$5.47 M -95.9% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 $20.1 M $2.4 M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 $5.87 M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 $6.16 M Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 $5.7 M Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q3 2016 $2 K* -$95 K -97.9% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $46 K -$53 K -53.5% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-11
Q3 2015 $97 K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $99 K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.